Microbial aetiology of healthcare associated pneumonia in Spain: A prospective, multicentre, case-control study

Thorax

Volumn 68, Issue 11, 2013, Pages 1007-1014

  Polverino, Eva ^a,b   Torres, Antoni ^a,b   Menendez, Rosario ^b,c   Cillóniz, Catia ^a,b   Valles, Jose Manuel ^c   Capelastegui, Alberto ^d   Marcos, M Angeles ^a   Alfageme, Inmaculada ^e   Zalacain, Rafael ^b,f   Almirall, Jordi ^b,g   Molinos, Luis ^h   Bello, Salvador ^b,i   Rodríguez, Felipe ^b,j   Blanquer, Josep ^b,k   Dorado, Antonio ^b,l   Llevat, Noelia ^m   Rello, Jordi ^b,n  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL DE GALDAKAO   (Spain)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f HOSPITAL DE CRUCES   (Spain)

^g Cures Intensives   (Spain)

^h HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^j HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^l HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^m PFIZER INC   (United States)

ⁿ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER; ACINETOBACTER IWOFFII; ARTICLE; BACTERIUM IDENTIFICATION; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; COXIELLA BURNETII; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; DRUG USE; DYSPHAGIA; ESCHERICHIA COLI; FEMALE; HOSPITAL READMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTICENTER STUDY; MYCOPLASMA PNEUMONIAE; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RELIABILITY; SCORING SYSTEM; SPAIN; SPECIES COMPARISON; STREPTOCOCCUS PNEUMONIAE;

AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL RATE;

EID: 84885781262     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203828     Document Type: Article

References (38)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
2. World Health Organization. The World Health Report 2001. Healthy life expectancy. WHO Statistics. 2001. http://whoint/whosis/hale/halecfm
3. European Commission. The Stockholm and Barcelona targets: increasing employment of older workers and delaying the exit from the labour market. Working paper of the Commission Services Employment and Social Affairs Brussels, EMPL/A/1 2 A.D. 2002.
4. European Commission. Employment in Europe 2003. Recent trends and prospect. Employment and Social Affairs. Luxembourg: Office for Official Publications of the European Communities, 2003.
5. Berman SJ. Infections in patients with end-stage renal disease. An overview. Infect Dis Clin North Am 2001;15:709-20; vii. (Pubitemid 32861461)
6. Merrer J, Santoli F, Appere dV, et al. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21:718-23.
7. Friedmann R, Raveh D, Zartzer E, et al. Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol 2009;30:534-42.
8. Brown RB, Cipriani D, Schulte M, et al. Community-acquired bacteremias from tunneled central intravenous lines: results from studies of a single vendor. Am J Infect Control 1994;22:149-51. (Pubitemid 24197690)
9. Valdivieso M, Gil-extremera B, Zornoza J, et al. Gram-negative bacillary pneumonia in the compromised host. Medicine (Baltimore) 1977;56:241-54. (Pubitemid 8111456)
10. Sickles EA, Young VM, Greene WH, et al. Pneumonia in acute leukemia. Ann Intern Med 1973;79:528-34.
11. Carratala J, Roson B, Fernandez-Sevilla A, et al. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med 1998;158:868-72. (Pubitemid 28183641)
12. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-62. (Pubitemid 43062645)
13. Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007;51:3568-73. (Pubitemid 47519345)
14. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009;135:633-40.
15. Schreiber MP, Chan CM, Shorr AF. Resistant pathogens in non-nosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest 2010;137:1283-8.
16. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2011;17:363-9.
17. Park HK, Song JU, Um SW, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med 2010;104:1729-35.
18. Jung JY, Park MS, Kim YS, et al. Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis 2011;11:61.
19. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011;17:1659-65.
20. Carratala J, Mykietiuk A, Fernandez-Sabe N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007;167:1393-9. (Pubitemid 47052438)
21. Polverino E, Dambrava P, Cilloniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010;65:354-9.
22. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011;53:107-13.
23. Ewig S, Welte T, Torres A. Is healthcare-associated pneumonia a distinct entity needing specific therapy? Curr Opin Infect Dis 2012;25:166-75.
24. Shorr AF, Zilberberg MD, Micek ST, et al. Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med 2008;168:2205-10.
25. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243-50. (Pubitemid 27044625)
26. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82. (Pubitemid 36560938)
27. Menendez R, Torres A, Aspa J, et al. [Community acquired pneumonia. New guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR)]. Arch Bronconeumol 2010;46:543-58.
28. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44(Suppl 2): S27-72. (Pubitemid 46290553)
29. Murray TJ, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975;50:339-44.
30. Rano A, Agusti C, Jimenez P, et al. Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001;56:379-87. (Pubitemid 32398129)
31. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003;29:1043-51. (Pubitemid 36918544)
32. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-60. (Pubitemid 39411203)
33. Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008;149:391-8.
34. Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007;167:950-5. (Pubitemid 46762758)
35. Marrie TJ, Wu L. Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU. Chest 2005;127:1260-70. (Pubitemid 46224289)
36. Sligl WI, Eurich DT, Marrie TJ, et al. Only severely limited, premorbid functional status is associated with short- and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest 2011;139:88-94.
37. Pavia AT. What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am 2013;27:157-75.
38. Ewig S, Klapdor B, Pletz MW, et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax 2012;67:132-8.